Malmström and colleagues 7 collected individual patient data from previous trials of BCG versus mitomycin C and performed a meta-analysis on 2,820 such data sets. After a median follow-up of 4.4 ...

The following is a summary of “Factors predicting local or systemic side effects related to intravesical BCG (Bacillus Calmette-Guérin) therapy: a retrospective observational study,” published in the ...

In examining why banks struggle to adapt, Nasdaq and BCG found that institutions have ... risk management, oversight, analysis, and innovation. The report advocates for a fundamental mindset ...

Altice USA (NYSE: ATUS) today announces that Dennis Mathew, Chairman and CEO, will present at the New Street Research and BCG Future of Connectivity Leaders Conference on Wednesday, March 26 ...

During the period of analysis, the combination showed a clinically ... trial assessing sasanlimab with Bacillus Calmette-Guérin (BCG), as induction treatment with or without maintenance in ...

ImmunityBio faces significant operational risks due to reliance on international BCG supplies and competition from Adstiladrin in NMIBC treatment. Financially, ImmunityBio struggles with high cash ...

The authorization was granted to ImmunityBio, the manufacturer of Anktiva ® (nogapendekin alfa inbakicept-pmln), an interleukin-15 receptor agonist, indicated with BCG for adult patients with BCG ...

Rising temperature and growing threat of climate change may increase default risk in 30 per cent of agri and housing loans portfolio in the next five years, according to an analysis by BCG.

It offers a detailed analysis of the market from the perspectives of providers, innovators, and payers, identifying key drivers of transformation across the region. India's competitive pricing and ...

Jane Akinyi (right) holding her baby while a medic adminster a Bacillus Calmette–Guérin vaccine(BCG) vaccine at Forest Dispensary in Nakuru on January 28,2019.Most of the hospitals in the ...